Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients
Journal of Proteomics · 2025
DOI: 10.1016/j.jprot.2024.105356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2025. Verfasst von Lin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China; College of Pulmonary & Critical Care Medicine, 8th Medical Center of Ch…. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Proteomics, SARS-CoV-2. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
In December 2022, China ceased the zero-COVID-19 policy, resulting in an increase in hospitalizations and deaths due to COVID-19, particularly among the elderly population. Predicting non-survivors aims to identify high-risk patients and enable targeted interventions to improve survival rates. Additionally, understanding factors affecting prognosis provides essential insights for further research and optimization of treatment strategies. We applied 4D-DIA mass spectrometry for serum proteome analysis and provided a comprehensive characterization of disease features in elderly patients within the Chinese population. Our study elucidated that immune disorders, lung damage, and cardiovascular disorders are predominant causes of death in these patients. Compared to clinical indices, proteomic analysis is more sensitive in tracing these disorders. We also provided a prediction panel for survival outcomes of elderly patients using levels of CXCL10, CXCL16 and IL1RA, which were validated by ELISA. These biomarkers will help improve predictive efficacy for survival outcomes in elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China; College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
- Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China.
- Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
- College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
- College of Pulmonary & Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China. Electronic address: xielx301@126.com.
- Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China; Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Wang, L., Tian, W., Wang, S., Liu, Y., Wang, H., Xiao, J., Yu, Z., Xie, L., & Chen, Y. (2025). Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105356
Vancouver
Wang L, Tian W, Wang S, Liu Y, Wang H, Xiao J, et al. Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients. Journal of Proteomics. 2025. doi:10.1016/j.jprot.2024.105356
BibTeX
@article{Wang2025,
author = {Wang, Lin and Tian, Wenmin and Wang, Sen and Liu, Yuhong and Wang, Hongli and Xiao, Junjie and Yu, Zhongkuo and Xie, Lixin and Chen, Yang},
title = {Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients},
journal = {Journal of Proteomics},
year = {2025},
doi = {10.1016/j.jprot.2024.105356}
}
EUVIMED